Therefore, in the current study, we aim to analyze the distribution of RS category and gene expression level among non-overweight, overweight and obese Chinese patients, to identify potential impact factors for the association of RS and BMI in HR-positive, HER2-negative breast cancer patients, and to explore the prognostic value of RS in Chinese patients with different BMI status. The gene discussed is ERBB2; the disease is breast cancer.